Chemotherapy-related cognitive dysfunction: current animal studies and future directions (Q38129330)

29 August 2017

title

Chemotherapy-related cognitive dysfunction: current animal studies and future directions (English)

1 reference

29 August 2017

1 reference

cognitive dysfunction

1 reference

2

S B Schagen

0 references

author name string

R Seigers

1

1 reference

29 August 2017

S B Schagen

2

1 reference

29 August 2017

O Van Tellingen

3

1 reference

29 August 2017

J Dietrich

4

1 reference

29 August 2017

publication date

1 December 2013

1 reference

Brain Imaging and Behavior

29 August 2017

published in

1 reference

29 August 2017

volume

7

1 reference

29 August 2017

issue

4

1 reference

29 August 2017

page(s)

453-459

1 reference

Candidate mechanisms for chemotherapy-induced cognitive changes

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Prophylactic action of linseed (Linum usitatissimum) oil against cyclophosphamide-induced oxidative stress in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Inflammation: a new candidate in modulating adult neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Endothelial cell effects of cytotoxics: balance between desired and unwanted effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Spatial learning deficits in rats after injection of vincristine into the dorsal hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Inflammation is detrimental for neurogenesis in adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

The effect of 5-fluorouracil on the long term survival and proliferation of cells in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Metallothionein induction reduces caspase-3 activity and TNFalpha levels with preservation of cognitive function and intact hippocampal neurons in carmustine-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Mathematical and Experimental Approaches to Identify and Predict the Effects of Chemotherapy on Neuroglial Precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Oxidant/antioxidant parameters and their relationship with chemotherapy in Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Neurofilament isoform alterations in the rat cerebellum following cytosine arabinoside administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Effects of AraC treatment on motor coordination and cerebellar cytoarchitecture in the adult rat. A possible protective role of NAC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Intracerebroventricular infusion of cytosine-arabinoside causes prepulse inhibition disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Cytosine arabinoside treatment impairs the remote spatial memory function and induces dendritic retraction in the anterior cingulate cortex of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Intrathecal methotrexate induces focal cognitive deficits and increases cerebrospinal fluid homocysteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Systemic methotrexate induces spatial memory deficits and depletes cerebrospinal fluid folate in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Reversible modulations of neuronal plasticity by VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Systemic administration of doxorubicin impairs aversively motivated memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

The Effects of Cyclophosphamide on Hippocampal Cell Proliferation and Spatial Working Memory in Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Fluoxetine Counteracts the Cognitive and Cellular Effects of 5-Fluorouracil in the Rat Hippocampus by a Mechanism of Prevention Rather than Recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Hippocampal brain amines in methotrexate-induced learning and memory deficit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Prophylactic action of melatonin against cyclophosphamide-induced oxidative stress in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Potent inhibition of cell proliferation in the hippocampal dentate gyrus of mice by the chemotherapeutic drug thioTEPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

The chemotherapy agent, thioTEPA, yields long-term impairment of hippocampal cell proliferation and memory deficits but not depression-related behaviors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Learning to learn: theta oscillations predict new learning, which enhances related learning and neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Cyclophosphamide-induced oxidative stress in brain: protective effect of hot short pepper (Capsicum frutescens L. var. abbreviatum).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Inhibition of cyclophosphamide-induced oxidative stress in rat brain by polar and non-polar extracts of Annatto (Bixa orellana) seeds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Effects of melatonin in reducing the toxic effects of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Vascular niche for adult hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Oxidative stress induced by methotrexate alone and in the presence of methanol in discrete regions of the rodent brain, retina and optic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Microglial physiology: unique stimuli, specialized responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Anticancer agents are potent neurotoxins in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Mechanisms of drug inhibition of signalling molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Inhibition of hippocampal cell proliferation by methotrexate in rats is not potentiated by the presence of a tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

A model of methotrexate encephalopathy: neurotransmitter and pathologic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Doxorubicin-induced central nervous system toxicity and protection by xanthone derivative of Garcinia Mangostana

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Persistent cognitive deficits, induced by intrathecal methotrexate, are associated with elevated CSF concentrations of excitotoxic glutamate analogs and can be reversed by an NMDA antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

The antimetabolite ara-CTP blocks long-term memory of conditioned taste aversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Chemotherapy drug thioTEPA exacerbates stress-induced anhedonia and corticosteroid responses but not impairment of hippocampal cell proliferation in adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

The Effects of Chemotherapy on Cognitive Function in a Mouse Model: A Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Cyclophosphamide impairs hippocampus-dependent learning and memory in adult mice: Possible involvement of hippocampal neurogenesis in chemotherapy-induced memory deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Neurotoxicity of methotrexate to hippocampal cells in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Acute treatment with methotrexate induces hippocampal dysfunction in a mouse model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

Cancer chemotherapy reduces plasma total antioxidant capacity in children with malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-013-9250-3

10.1007/S11682-013-9250-3

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1037210205

0 references

1 reference